Daniel Wolfe | Deputy Direct, BARDA CBRN Medical Countermeasures
Biomedical Advanced Research And Development Authority

Daniel Wolfe, Deputy Direct, BARDA CBRN Medical Countermeasures, Biomedical Advanced Research And Development Authority

Dr. Wolfe currently serve as the Branch Chief for the Vaccine Program in support of the CBRN Division of the Biomedical Advanced Research and Development Authority (BARDA). In doing so, he leads the advanced development and management of complex vaccine projects targeting biological threats. The branch is comprised of team of interdisciplinary experts providing technical oversight of the manufacturing, testing, clinical, non-clinical, and regulatory aspects of these vaccine programs. He leads a program of vaccines targeting priority biological threats, leading them across the ‘valley of death’ into advanced development and ultimately to FDA licensure. In doing so, he and his team continues to improve the preparedness posture for the United States in the event of a biological attack or outbreak. His background includes a Ph.D. in Pathobiology, studying mechanisms of vaccine-mediated immunity and vaccine escape.

Appearances:



Pre-Congress Workshops - Monday 28th October @ 10:00

Platform Technologies Workshop [AM1]

Session led by: pfizer
Session led by: quantoom-biosciences
Session led by: etherna
Session led by: adaptvac

Day 3 - Thursday 31st October @ 13:30

Vaccines On Demand: How Far Can We Downsize Modular Manufacturing?

last published: 15/Oct/24 10:25 GMT

back to speakers